Emile Gogineni
Overview
Explore the profile of Emile Gogineni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sreenivasan S, Najjar S, Ma D, Begley S, Wuu Y, Rana Z, et al.
Adv Radiat Oncol
. 2025 Feb;
10(3):101709.
PMID: 39949525
Purpose: Despite recent advancements in the treatment of atypical meningioma, control rates in high-risk patients continue to be suboptimal. Stereotactic radiosurgery (SRS) offers the ability to achieve improved local control...
2.
Huttinger Z, Gogineni E, Baliga S, Blakaj D, Bhateja P, Bonomi M, et al.
Oral Oncol
. 2025 Jan;
161():107179.
PMID: 39827592
Background: Induction chemotherapy (IC) followed by chemoradiation (CRT) is one treatment approach for patients with locoregionally advanced oropharyngeal squamous cell carcinoma (OPSCC) associated with human papillomavirus (HPV). This pilot study...
3.
Jhawar S, Haring C, Pan X, Ma J, Bhateja P, Kubi E, et al.
Int J Cancer
. 2024 Dec;
156(8):1656-1663.
PMID: 39679923
Circulating tumor tissue modified (TTMV)-HPV DNA has emerged as a promising biomarker in human papillomavirus associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). The objective of this study was to assess ctHPVDNA...
4.
Ma S, Zhu S, Virk J, Koempel A, Bhateja P, Gogineni E, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2450272.
PMID: 39652345
Importance: National Comprehensive Cancer Network guidelines recommend weekly cisplatin as an alternative concurrent systemic therapy for definitive chemoradiation in patients with head and neck cancer. However, the impact of different...
5.
Bhateja P, Liu X, Baliga S, Gogineni E, Jhawar S, Mitchell D, et al.
J Med Virol
. 2024 Nov;
96(11):e70086.
PMID: 39564895
HPV viral E6 and E7 onco-proteins play a well-known role in carcinogenesis. Host genomic alterations also play a key role in the development of HPV-related oropharyngeal cancer and have been...
6.
Ladbury C, Sidiqi B, Cantrell N, Jones G, Skalina K, Fekrmandi F, et al.
Pract Radiat Oncol
. 2024 Oct;
PMID: 39424129
Purpose: Data informing the safety, efficacy, treatment logistics, and dosimetry of stereotactic body radiation therapy (SBRT) for lung tumors has primarily been derived from patients with favorably located solitary tumors....
7.
Daly S, Soto J, Gonzalez S, Ankrah N, Gogineni E, Andraos T, et al.
Clin Neurol Neurosurg
. 2024 Sep;
246:108550.
PMID: 39278006
Introduction: Medically refractory epilepsy (MRE) occurs in about 30 % of patients with epilepsy, and the treatment options available to them have evolved over time. The classic treatment for medial...
8.
Aziz K, Koffler D, Vassantachart A, Rattani A, Ankrah N, Gogineni E, et al.
Pract Radiat Oncol
. 2024 Sep;
15(1):54-68.
PMID: 39233007
Purpose: Spinal stereotactic body radiation therapy (SBRT) has become the standard of care in management of patients with limited sites of metastatic disease, radioresistant histologies, painful vertebral metastases with long...
9.
Gogineni E, DiCostanzo D, Blakaj D
Pract Radiat Oncol
. 2024 Sep;
14(5):469-470.
PMID: 39218531
No abstract available.
10.
Gogineni E, Chen H, Cruickshank Jr I, Koempel A, Gogineni A, Li H, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123430
Proton therapy has been shown to provide dosimetric benefits in comparison with IMRT when treating prostate cancer with whole pelvis radiation; however, the optimal proton beam arrangement has yet to...